G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,813,321 | -55.2% | 333,945 | +3.1% | 0.48% | -55.6% |
| Q3 2022 | $4,046,000 | +6.8% | 323,945 | -57.8% | 1.09% | -24.8% |
| Q2 2022 | $3,790,000 | +2.0% | 767,235 | +57.0% | 1.45% | -8.4% |
| Q1 2022 | $3,714,000 | +58.2% | 488,635 | +112.4% | 1.58% | +102.7% |
| Q4 2021 | $2,348,000 | +249.9% | 230,000 | +360.0% | 0.78% | +297.4% |
| Q3 2021 | $671,000 | -38.8% | 50,000 | 0.0% | 0.20% | -23.1% |
| Q2 2021 | $1,097,000 | -8.8% | 50,000 | 0.0% | 0.26% | +5.8% |
| Q1 2021 | $1,203,000 | +7.9% | 50,000 | -19.4% | 0.24% | -23.2% |
| Q4 2020 | $1,115,000 | +14.9% | 62,000 | -26.2% | 0.31% | -9.0% |
| Q3 2020 | $970,000 | -9.1% | 84,000 | +90.9% | 0.34% | -17.1% |
| Q2 2020 | $1,067,000 | – | 44,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |